Superworth

Sight Sciences price to book ratio SGHT

Market value divided by the book value of the company's net assets, since 2021.

Today, Nov 2, 2026
9.5×
5-year median
2.8×
Against its 5-year history
99th
percentile: 0 is its lowest day, 100 its highest
5-year range
0.5× to 9.7×
Peer median
3.4×

Sight Sciences' price to book ratio is 9.5× as of Nov 2, 2026.

That is above its 5-year median of 2.8×, higher than on 99% of days in the last 5 years.

Over that time it ranged from 0.5× in Oct 2023 to 9.7× in Oct 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 3.4×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.5×2.9×9.7×
20257.3×1.3×7.3×
20241.9×1.6×3.5×
20232.0×0.5×3.7×
20223.4×1.4×3.5×
20213.4×3.4×4.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Sight Sciences' size, closest first, today.

CompanyPrice to book ratio
SGHTSight Sciences9.5×
TCMDTactile Systems Technology2.3×
MOVMovado1.4×
EMBCEmbectan/m
INFUInfuSystem4.7×
IRMDIradimed9.5×
IARTIntegra Lifesciences1.0×
BVSBioventus4.8×
UTMDUtah Medical Products1.8×
STAAStaar Surgical3.4×
CDRECadre3.9×
Peer median3.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Sight Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.